ONCOGENEX PHARMACEUTICALS IN - COM (OGXI)

CUSIP: 68230A106

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Equity / COM
Total 13F shares
6,051,026
Share change
-868,678
Total reported value
$71,076,318
Put/Call ratio
152%
Price per share
$11.76
Number of holders
71
Value change
-$4,564,568
Number of buys
39
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP 68230A106?
CUSIP 68230A106 identifies OGXI - ONCOGENEX PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ONCOGENEX PHARMACEUTICALS IN - COM (OGXI) as of Q1 2014

As of 31 Mar 2014, ONCOGENEX PHARMACEUTICALS IN - COM (OGXI) was held by 71 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,051,026 shares. The largest 10 holders included BlackRock Institutional Trust Company, N.A., Abingworth LLP, Visium Asset Management, LP, BlackRock Fund Advisors, VANGUARD GROUP INC, Allianz Asset Management AG, WASATCH ADVISORS INC, BOGLE INVESTMENT MANAGEMENT L P /DE/, State Street Corp, and BlackRock Advisors LLC. This page lists 71 institutional shareholders reporting positions in this security for the Q1 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.